A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers

Clinical trial NCT04879849 · COMPLETED

Trial details

NCT number: NCT04879849
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Triple Negative Breast Neoplasms Squamous Cell Carcinoma of Head and Neck

Start date: 2021-09-09
Primary completion: 2024-04-30
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.